Trial intelligence / Profile preview

Teneligliptin Effect on Forearm Endothelial Function in Diabetics (EDPI)

jRCT1091220223Not yet recruiting

Sponsor
Bonpei Takase
Start
Aug 2015
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of teneligliptin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Bonpei Takase. Primary endpoint: endothelial function. Planned start Aug 2015; status: not yet recruiting.

02

Drugs

teneligliptin
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on jRCT1091220223.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1091220223.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call